P2RX7 and neoplasm: Indeed, activation of the P2RX7/IL-18 axis with HEI3090 sensitized lung and melanoma tumors to immunotherapy, cured 80% of mice and protected them from a tumor rechallenge, highlighting the potency of IL-18 in generating long lasting memory T cells in tumor models [110].